Megalencephaly

Megalencephaly, often referred to as macrencephaly and abbreviated as MEG, refers to a neurodevelopmental disorder where there's an abnormal enlargement of the brain. Specifically, the brain's weight is found to be 2.5 standard deviations above the mean for the general population, making it a distinguishing and significant feature of the condition.

Diagnosis

The presence of megalencephaly is typically identified at birth or during infancy. The primary diagnostic tool for confirming this condition is Magnetic Resonance Imaging (MRI). The imaging provides clear insights into the size and structure of the brain, confirming the suspicion of megalencephaly.

Causes

Current research posits that a mutation in the PI3K-AKT pathway serves as the central etiological factor. This mutation is associated with unchecked proliferation of brain tissues, culminating in the enlargement characteristic of megalencephaly. As science delves deeper into understanding the genetic roots of this condition, two distinct syndromes associated with brain overdevelopment have been identified:

• Megalencephaly-capillary malformation (MCAP): This syndrome combines the features of megalencephaly with vascular abnormalities.
• Megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH): This is a more complex manifestation, involving not only brain enlargement but also the presence of additional fingers or toes, abnormal cortical development, and accumulation of cerebrospinal fluid in the brain.

Prevalence

The prevalence of megalencephaly in the general population is approximately 2%, meaning 1 out of 50 children might exhibit characteristics consistent with this condition.

Associated Conditions

While several neuropsychiatric disorders can emerge in the context of megalencephaly, the most common association appears to be with autism. Autism, a developmental disorder affecting communication and behavior, seems to have a higher likelihood of occurrence in individuals with megalencephaly.

Treatment and Management

As of now, there's no definitive cure for megalencephaly. Interventions primarily focus on addressing and reducing the deficits and challenges associated with comorbid conditions like autism. Therapeutic approaches might involve physical therapy, behavioral therapy, and sometimes medication to manage specific symptoms.

Research in the field is ongoing and is mainly pivoted toward the development of inhibitors that can target and modulate the mutated pathway responsible for the condition.

See Also

• Neurodevelopmental Disorders
• Brain development
• Autism Spectrum Disorder

References

Megalencephaly Resources
Latest articles Most recent articles Ongoing trials	Wikipedia